Investigation of the Safety and Efficacy of Long Term Administration of Eszopiclone in Insomnia Patients

Eisai

Status: Completed

Conditions: Insomnia

Treatments: Drug: Eszopiclone

Study type: Observational

Funder types: Industry

Identifiers

NCT02455271

LUN02T

Details and patient eligibility

About

To investigate the safety and efficacy of administration of eszopiclone for 6 months in insomnia participants.

Enrollment: 438 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

1. Participants who have completed LUN01S and need to continue eszopiclone

Trial design

438 participants in 1 patient group

Participants with insomnia

Description:

Participants with insomnia who will receive eszopiclone per approved label.

Treatment:

Drug: Eszopiclone